Referred to the Senate Health & Long-Term Care Committee on January 10, 2022
Substitute offered in the Senate on January 26, 2022
Requires all cost-sharing amounts paid by or on behalf of an enrollee to count toward the enrollee's applicable cost-sharing requirement under certain circumstance.
Referred to the Senate Rules Committee on January 27, 2022
Referred to the House Health Care & Wellness Committee on February 11, 2022
Amendment offered by Rep. Eileen Cody (West Seattle) (D) on March 2, 2022
Exempts drugs with a therapeutic equivalent preferred under the health plan's formulary from the requirement that a health carrier count all cost-sharing amounts regardless of source (except in circumstances involving prior authorization, step therapy, or an exception process). Requires a health carrier to count all cost- sharing amounts regardless of source throughout an exception request process, including any appeal of a denial of an exception request and including any time between the completion of an exception request process conducted by a health care benefits manager and when the health care benefits manager communicates the status of the request to the health carrier.
The amendment passed by voice vote in the House on March 2, 2022